<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21" class="ref">
 <label class="label">21.</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Ishii</surname>
    <given-names class="given-names">Y</given-names>
   </name>
   <name class="name">
    <surname class="surname">Saeki</surname>
    <given-names class="given-names">K</given-names>
   </name>
   <name class="name">
    <surname class="surname">Liu</surname>
    <given-names class="given-names">M</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sasaki</surname>
    <given-names class="given-names">F</given-names>
   </name>
   <name class="name">
    <surname class="surname">Koga</surname>
    <given-names class="given-names">T</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kitajima</surname>
    <given-names class="given-names">K</given-names>
   </name>
   <etal class="etal"/>
  </person-group>. 
  <article-title class="article-title">Leukotriene B
   <sub class="sub">4</sub> receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins
  </article-title>. 
  <source class="source">FASEB J.</source> (
  <year class="year">2015</year>) 
  <volume class="volume">30</volume>:
  <fpage class="fpage">933</fpage>â€“
  <lpage class="lpage">47</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1096/fj.15-279653</pub-id>
  <?supplied-pmid 26527063?>
  <pub-id pub-id-type="pmid" class="pub-id">26527063</pub-id>
 </mixed-citation>
</ref>
